- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05422586
Way To Drive Validation Study
June 1, 2023 updated by: M. Kit Delgado, MD, University of Pennsylvania
Validation Study of Penn's Way to Drive Telematics Research Application
Way to Drive is a smart phone-based driving telematics application.
Research participants are invited to download the app, which uses phone sensors to track driving behaviors including mileage, hard breaking events, and handheld phone use while driving, measured as the phone screen being unlocked while the phone is in the hand and the vehicle is in motion.
Before the study team launches a clinical trial using the app, the researchers will test its capabilities and reliability.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
62
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
Adults who completed in the study team's recent clinical trial with User Based Insurance customers and stated interest in being contacted about further research opportunities.
The adults participated in a driving monitoring study (May 2021) and met the eligibility criteria, including 4 trips per week.
Description
Inclusion Criteria:
- 18 or older (only adult drivers will be invited)
- Willing to download Way to Drive and allow it to track the user's location while the user is in motion (i.e. over 5mph)
- Will make at least 4 driving trips per week for the duration of the study.
- Able to provide informed consent
Exclusion Criteria:
- Under 18 Cannot complete online surveys
- Does not have smart phone
- Not willing to download Way to Drive app and allow location tracking while in motion
- Will not be driving at least 4 times per week during the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of driving trips classified correctly (driver/passenger) by the Way to Drive Telematics App
Time Frame: 28 days
|
Measured by the driving and behavior when the car is in motion by the Way to Drive app.
|
28 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of driving events accurately captured (trip captured or missing) by Way to Drive Telematics App
Time Frame: 28 days
|
Measured using phone sensor data to detect when the vehicle is in motion.
|
28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mucio Delgado, University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 17, 2022
Primary Completion (Actual)
August 13, 2022
Study Completion (Actual)
August 13, 2022
Study Registration Dates
First Submitted
June 13, 2022
First Submitted That Met QC Criteria
June 13, 2022
First Posted (Actual)
June 16, 2022
Study Record Updates
Last Update Posted (Actual)
June 5, 2023
Last Update Submitted That Met QC Criteria
June 1, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 849755
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Deidentified participant data will be made available to other researchers upon request.
IPD Sharing Time Frame
Data will be made 5 weeks after request and indefinitely thereafter.
IPD Sharing Supporting Information Type
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Distracted Driving
-
University of PennsylvaniaProgressive Auto InsuranceCompletedDriving Impaired | Distracted DrivingUnited States
-
University of PennsylvaniaGeneral Motors (GM)CompletedDistracted Driving | Impaired Driving | Driving BehaviorsUnited States
-
Minnesota HealthSolutionsChildren's Hospital of PhiladelphiaRecruiting
-
Children's Hospital of PhiladelphiaMinnesota HealthSolutionsCompletedDistracted DrivingUnited States
-
University of PennsylvaniaAAA Foundation for Traffic SafetyRecruitingBehavioral Economics | Distracted Driving | Injury PreventionUnited States
-
Seattle Children's HospitalWithdrawn
-
Rush University Medical CenterCompletedImpairment | Driving | Intoxication | Alcohol Impaired DrivingUnited States
-
Seoul National University HospitalRecruitingAutomobile DrivingKorea, Republic of
-
University of LiegeCompleted
-
Naurex, Inc, an affiliate of Allergan plcCompleted